Mike Nolan - CEO of Freenome
Pioneering the most comprehensive multiomics platform for early cancer detection using a routine blood draw.
Timeline
2014
- Founded
2017
- Partnered
Fierce Biotech, Freenome secures $270M to boost its colorectal cancer blood test, expand trial nationwide - August 26, 2020
CNBC, These start-ups are racing to help doctors detect cancer early with a simple blood test - February 1, 2020
Zoba
Enterprise